// App-Quantinova.ai

OR06-2 : AKT1 Has Dual Actions on the Transcriptional Activity of the Glucocorticoid Receptor: Implications to Glucocorticoid Resistance Observed in Pediatric Acute Lymphoblastic Leukemia and Its Treatment

Researchers

Presenter

  • Tanwir Habib

Principal Investigators

  • N/A

Medical Centers

  • Sidra Medical Research Center, Doha, Qatar

Locations

  • Qatar

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Glucocorticoid resistance

  • Colorectal Cancer

  • Thymomas

  • Solid malignancies

Biomarkers

  • AKT Serine

  • Breakpoint Cluster Region

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Theta

Drug/Treatment

  • Glucocorticoid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved